Results 151 to 160 of about 1,246,657 (288)
Perinatal lead (Pb) exposure and alterations to amyloid beta and metabolic profiles in the brain. [PDF]
Morgan RK +10 more
europepmc +1 more source
A hierarchical strategy integrates linker engineering, amyloid‐guided self‐assembly, and magnetic immobilization to construct recyclable DPAO4‐DMAO7 enzymatic nanofibers. The resulting magnetic composites enable biogenic amine conversion in complex food matrices and simulated wastewater, while rapid magnetic separation supports repeated reuse. The work
Shuangping Liu +5 more
wiley +1 more source
Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease? [PDF]
He CY +5 more
europepmc +1 more source
Automating AI Discovery for Biomedicine Through Knowledge Graphs and Large Language Models Agents
This work proposes a novel framework that automates biomedical discovery by integrating knowledge graphs with multiagent large language models. A biologically aligned graph exploration strategy identifies hidden pathways between biomedical entities, and specialized agents use this pathway to iteratively design AI predictors and wet‐lab validation ...
Naafey Aamer +3 more
wiley +1 more source
Sleep fragmentation correlates with amyloid beta deposition at brain autopsy. [PDF]
Rudolf MA, Ng YT, Lieberman AP.
europepmc +1 more source
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Diana L Castillo-Carranza,1,2 Marcos J Guerrero-Muñoz,1,2 Rakez Kayed1–31Mitchell Center for Neurodegenerative Diseases, 2Departments of Neurology, Neuroscience, and Cell Biology, 3Sealy Center for Vaccine Development, University of Texas ...
Castillo-Carranza DL +2 more
core
Artificial intelligence is redefining network pharmacology (NP). By integrating knowledge graph engineering, geometric deep learning, multiomics anchoring, and generative reasoning, AI‐driven NP (AI‐NP) transforms static target mapping into dynamic, predictive modeling.
Cong Wang +9 more
wiley +1 more source
Amyloid-beta-targeting monoclonal antibodies in early Alzheimer's disease: a cochrane review summary and appraisal for the neurological community. [PDF]
Santos DH, da Silva AMP.
europepmc +1 more source
An ultra‐fast small‐sample AI consensus pipeline combines co‐folding and docking to target structure‐lacking p53 monomers. Its optimal mini‐protein binder shows robust interfacial affinity and promising druggability, supplying unprecedented antitumor p53 templates.
Ningyao Li +9 more
wiley +1 more source
Parallel neuroinflammatory pathways to cerebrovascular burden and amyloid beta in Alzheimer's disease. [PDF]
Rizvi B +18 more
europepmc +1 more source

